Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | S-1/A |
| Revenues: |
| Patient services | 93.6 | 106.9 | 119.9 | | | | | |
| Product | 9.5 | 11.1 | | | | | | |
| Research services | 8.3 | 1.1 | | | | | | |
| Total revenues [+] | 111.5 | 119.0 | 119.9 | 140.6 | 120.5 | 73.0 | 33.9 | 30.9 |
| Products | 9.5 | 11.1 | | 0.4 | | | | |
| Services | 8.3 | 1.1 | | | | | | |
| Healthcare | 93.6 | 106.9 | 119.9 | 140.2 | | | | |
| Revenue growth [+] | -6.3% | -0.8% | -14.7% | 16.7% | 65.0% | 115.2% | 9.6% | |
| Patient services | -12.4% | -10.9% | | | | | | |
| Product | -14.1% | | | | | | | |
| Research services | 672.3% | | | | | | | |
| Cost of goods sold [+] | 45.6 | 49.1 | 47.5 | 48.7 | 39.9 | 25.5 | 12.7 | 17.0 |
| Cost of product sales | 5.1 | 6.2 | | | | | | |
| Cost of services | 3.7 | 0.6 | | | | | | |
| Gross profit | 65.9 | 69.9 | 72.4 | 91.9 | 80.5 | 47.5 | 21.2 | 14.0 |
| Gross margin | 59.1% | 58.8% | 60.4% | 65.4% | 66.9% | 65.0% | 62.6% | 45.2% |
| Selling, general and administrative [+] | 58.2 | 62.8 | 64.0 | 73.8 | 48.7 | 35.4 | 22.1 | 20.3 |
| Sales and marketing | 25.6 | 27.8 | 29.3 | 34.7 | 21.1 | 16.0 | 6.4 | 6.5 |
| General and administrative | 32.6 | 35.0 | 34.7 | 39.2 | 27.6 | 19.4 | 15.6 | 13.9 |
| Research and development | 4.7 | 5.7 | 4.9 | 5.8 | 4.0 | 3.8 | 3.6 | 3.4 |
| Other operating expenses | 14.4 | 13.9 | 23.2 | 33.0 | 18.1 | 8.1 | | |
| EBITDA [+] | -2.0 | -0.4 | -7.6 | -9.7 | 18.4 | 4.8 | -1.8 | -3.8 |
| EBITDA growth | 462.1% | -95.3% | -21.5% | -152.8% | 283.7% | -361.5% | -52.1% | |
| EBITDA margin | -1.8% | -0.3% | -6.4% | -6.9% | 15.3% | 6.6% | -5.4% | -12.4% |
| Depreciation | 8.0 | 10.9 | 11.7 | 10.1 | 7.7 | 3.8 | 2.7 | 5.9 |
| EBITA | -10.0 | -11.3 | -19.3 | -19.8 | 10.7 | 1.0 | -4.5 | -9.7 |
| EBITA margin | -9.0% | -9.5% | -16.1% | -14.1% | 8.9% | 1.4% | -13.2% | -31.3% |
| Amortization of intangibles | 1.3 | 1.2 | 0.4 | 0.9 | 1.0 | 0.8 | | |
| EBIT [+] | -11.4 | -12.5 | -19.7 | -20.6 | 9.7 | 0.2 | -4.5 | -9.7 |
| EBIT growth | -8.9% | -36.6% | -4.6% | -313.1% | 3904.5% | -105.4% | -53.7% | |
| EBIT margin | -10.2% | -10.5% | -16.4% | -14.7% | 8.0% | 0.3% | -13.2% | -31.3% |
| Non-recurring items [+] | 1.8 | 48.8 | | | | | | |
| Asset impairment | | 46.0 | | | | | | |
| Interest expense, net [+] | -0.1 | -0.1 | -0.1 | -0.2 | -1.0 | 0.6 | 3.2 | 1.8 |
| Interest expense | 0.3 | | 0.0 | 0.0 | 0.2 | 2.2 | 3.3 | 1.9 |
| Interest income | 0.4 | 0.1 | 0.1 | 0.2 | 1.2 | 1.6 | 0.1 | 0.1 |
| Pre-tax income | -13.1 | -61.2 | -19.6 | -20.5 | 10.7 | -0.4 | -7.6 | -11.5 |
| Income taxes | -0.9 | 0.2 | 0.3 | 0.0 | 1.5 | 0.0 | 0.0 | 0.0 |
| Tax rate | 6.9% | | | | 13.9% | 0.0% | 0.0% | 0.0% |
| Net income | -12.2 | -61.4 | -19.9 | -20.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | -10.9% | -51.6% | -16.6% | -14.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| Basic EPS [+] | ($0.49) | ($2.51) | ($0.82) | ($0.86) | $0.36 | ($2.89) | ($2.63) | ($4.04) |
| Growth | -80.5% | 205.3% | -4.4% | -339.2% | -112.5% | 9.9% | -34.9% | |
| Diluted EPS [+] | ($0.49) | ($2.51) | ($0.82) | ($0.86) | $0.29 | ($2.89) | ($2.63) | ($4.04) |
| Growth | -80.5% | 205.3% | -4.4% | -395.4% | -110.1% | 9.9% | -34.9% | |
| |
| Shares outstanding (basic) [+] | 24.9 | 24.4 | 24.1 | 23.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Growth | 2.1% | 1.3% | 1.4% | 129454.2% | 509.2% | 3.6% | 2.5% | |
| Shares outstanding (diluted) [+] | 24.9 | 24.4 | 24.1 | 23.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Growth | 2.1% | 1.3% | 1.4% | 104810.0% | 652.4% | 3.6% | 2.5% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|